Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, ...

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...

Researchers have made significant advancements in understanding the earliest stages of stomach cancer, a leading cause of cancer-related deaths worldwide, through two recent innovative studies. With a ...

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

A new MD Anderson antibody, 77A, restores treatment response in resistant myeloma, lymphoma and solid tumors, offering a ...